MedCity News June 22, 2021
Anuja Vaidya

Five Blue Cross Blue Shield plans provided funding to establish Evio, which aims to improve clinical outcomes and cut drug costs. It will initially only offer services to the founding health plans, including data analytics to determine drug performance and enhancing outcomes-based contracting.

Five Blue Cross Blue Shield plans have joined forces to establish Evio, a new independent pharmacy solutions startup.

The for-profit startup aims to rein in drug costs and improve clinical outcomes.

The founding insurers, who invested the same undisclosed sum, are Blue Cross Blue Shield of Massachusetts, Blue Cross Blue Shield of Michigan, Blue Shield of California, Highmark Inc., and Independence Blue Cross, which together provide coverage to more than 20 million members across the country.

Initially,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Payer, Pharma, Pharma / Biotech
Why Blue Shield of California partners with Big Tech
Understanding CMS’ AHEAD Model: Medicare Hospital Global Budget Design and Implications
UnitedHealth pays $3.3B to providers following Change hack
Why Should Payers Spend Money on Digital Diabetes Solutions?
Largest payers' membership mix

Share This Article